Clinical Performance of the Checkable Medical At-Home Strep A Test
- Conditions
- Streptococcus Pyogenes InfectionRespiratory Tract InfectionsPharyngitis
- Interventions
- Diagnostic Test: untrained lay user performs investigational diagnostic test
- Registration Number
- NCT05107362
- Lead Sponsor
- Checkable Medical Inc
- Brief Summary
The Checkable Medical At-Home Strep A Test is a rapid chromatographic immunoassay for the qualitative detection of Group A Strep (GAS) antigens from throat swabs. The purpose of the study is to evaluate the clinical performance of the investigational device (i.e., sensitivity, specificity, NPV and PPV) when used by untrained lay persons to detect the presence of Group A Streptococcal antigens in throat swab specimens from individuals five years of age and older with signs and symptoms of pharyngitis, such as fever and sore throat.
- Detailed Description
The study is a prospective, consecutive, non-interventional multicenter study to evaluate the clinical performance of the Checkable Medical At-Home Strep A Test when the test is performed by non-trained adult lay users.
1. Patients or parents/legal guardians of patients presenting with signs and symptoms of pharyngeal GAS infections will be recruited at primary care or urgent care clinics.
2. Informed consent will be obtained from adult subjects and from the parents/guardians of pediatric subjects. Pediatric subjects 7 years of age or greater will be asked for their assent.
3. The lay user will be provided with a Checkable Medical At-Home Strep A Test kit. The user and patient will be provided with a quiet, private space where the user can collect the throat swab specimen and perform the investigational test.
4. Once the lay user has collected the swab sample for the Checkable Medical At-Home Strep A Test and performed the test, she/he will document the test result. The Checkable Medical At-Home Strep A Test result is not to be shared with members of the site team who are providing healthcare to the subject.
5. When all sample collection, testing and interpretation activities related to the investigational test are completed, a healthcare provider at the study site will collect two additional swab samples. One of these samples will be sent to a central lab where it will be cultured for GAS. An additional sample will be tested using the organization's standard of care (SOC) rapid Strep A test.
6. Subjects will be diagnosed and treated in accordance with routine SOC which may include an FDA-cleared rapid GAS test. The Checkable Medical At-Home Strep A Test will not be used to diagnose or treat study subjects.
7. This study will take place in at least six sites in at least three different regions of the United States.
8. The results from the Checkable Medical At-Home Strep A Test will be used to compare with the diagnostic truth obtained through culture to compute diagnostic accuracy parameters including sensitivity, NPV, specificity and PPV.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1347
-
Subjects seeking medical care for two or more of the following signs/symptoms of pharyngeal streptococcal infections:
- pharyngeal pain [with or without swallowing],
- tonsillar swelling with exudates,
- pharyngeal erythema,
- tender cervical lymphadenopathy,
- fever.
-
Subjects who have not received antibiotic treatment within the past 14 days.
-
Subjects (or their parents/guardians) provide written informed consent/assent to participate in the study
- Lay users who are accompanying patients are unwilling/unable to collect throat swab sample from a child or adult.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Symptomatic Adult and Pediatric Subjects untrained lay user performs investigational diagnostic test Untrained lay user to collect throat swab specimen and perform investigational test.
- Primary Outcome Measures
Name Time Method Clinical Sensitivity and Clinical Specificity 1 day Sensitivity is the proportion of subjects with a positive bacterial culture that are also positive in the investigational Strep A test (+).
Specificity is the proportion of subjects with a negative bacterial culture that are also negative in the investigational Strep A test (-).
- Secondary Outcome Measures
Name Time Method Negative Predictive Value 1 day Negative Predictive Value (NPV) is the proportion of subjects with negative investigational Strep A test results who also have negative cultures (diagnostic truth); calculated as 100 x d/(c+d).
Trial Locations
- Locations (18)
WellNow Urgent Care and Research
🇺🇸Troy, Ohio, United States
Pediatric Associates
🇺🇸Houston, Texas, United States
North Houston Internal Medicine and Pediatric Clinic
🇺🇸Tomball, Texas, United States
Angel Kids Pediatrics
🇺🇸Jacksonville, Florida, United States
Tribe Clinical Research
🇺🇸Greenville, South Carolina, United States
MDFirst
🇺🇸Lancaster, South Carolina, United States
AFC Urgent Care
🇺🇸Easley, South Carolina, United States
Infinitive Bio Research
🇺🇸Edison, New Jersey, United States
Elite Clinical Trials
🇺🇸Blackfoot, Idaho, United States
Robertson Pediatrics
🇺🇸Beverly Hills, California, United States
L&A Morales Health Care
🇺🇸Miami, Florida, United States
Waggoner Pediatrics
🇺🇸Clive, Iowa, United States
Axis Clinicals
🇺🇸Dilworth, Minnesota, United States
Twelve Corners Pediatrics
🇺🇸Rochester, New York, United States
Plains Clinical Research
🇺🇸Fargo, North Dakota, United States
Trinity Health
🇺🇸Minot, North Dakota, United States
Santa Clara Family Clinic
🇺🇸Houston, Texas, United States
Pediatric Center
🇺🇸Richmond, Texas, United States